[go: up one dir, main page]

HK1213812A1 - 包含 化合物與活性成分的組合物及其製備方法 - Google Patents

包含 化合物與活性成分的組合物及其製備方法

Info

Publication number
HK1213812A1
HK1213812A1 HK16101910.7A HK16101910A HK1213812A1 HK 1213812 A1 HK1213812 A1 HK 1213812A1 HK 16101910 A HK16101910 A HK 16101910A HK 1213812 A1 HK1213812 A1 HK 1213812A1
Authority
HK
Hong Kong
Prior art keywords
compound
preparation
active ingredient
containing composition
composition
Prior art date
Application number
HK16101910.7A
Other languages
English (en)
Inventor
崔坤元
梁東
陳波
Original Assignee
Xiamen Chengkun Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xiamen Chengkun Biotech Co Ltd filed Critical Xiamen Chengkun Biotech Co Ltd
Publication of HK1213812A1 publication Critical patent/HK1213812A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16101910.7A 2015-08-03 2016-02-19 包含 化合物與活性成分的組合物及其製備方法 HK1213812A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510466904.8A CN105079021A (zh) 2015-08-03 2015-08-03 包含m10c1化合物与活性成分的组合物及其制备方法

Publications (1)

Publication Number Publication Date
HK1213812A1 true HK1213812A1 (zh) 2016-07-15

Family

ID=54560952

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101910.7A HK1213812A1 (zh) 2015-08-03 2016-02-19 包含 化合物與活性成分的組合物及其製備方法

Country Status (3)

Country Link
CN (1) CN105079021A (zh)
HK (1) HK1213812A1 (zh)
WO (1) WO2017020826A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105079021A (zh) * 2015-08-03 2015-11-25 厦门成坤生物技术有限公司 包含m10c1化合物与活性成分的组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2430168B1 (en) * 2009-05-16 2016-12-21 Kunyuan Cui Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules
JP6124078B2 (ja) * 2010-08-26 2017-05-10 ツイ，クンユァン 巨大環状脂肪族化合物及びその応用
CN103333890B (zh) * 2012-12-21 2015-04-15 厦门成坤生物技术有限公司 治疗乙型病毒性肝炎的rna干扰制剂
CN104107437B (zh) * 2013-06-09 2015-08-26 厦门成坤生物技术有限公司 一种用于治疗乙型病毒性肝炎的rna干扰组合物及其制备方法
CN105079021A (zh) * 2015-08-03 2015-11-25 厦门成坤生物技术有限公司 包含m10c1化合物与活性成分的组合物及其制备方法

Also Published As

Publication number Publication date
WO2017020826A1 (zh) 2017-02-09
CN105079021A (zh) 2015-11-25

Similar Documents

Publication Publication Date Title
EP3299369A4 (en) Pyrido-azaheterecydic compound and preparation method and use thereof
EP3130354A4 (en) Posaconazole pharmaceutical composition and preparation method, application and pharmaceutical preparation thereof
IL253538B (en) Heterocyclic compound and pharmaceutical compound containing it
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
PL3391884T3 (pl) Preparat do wchłaniania przezskórnego
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
HK1243927A1 (zh) 含有茶皂醇衍生物作爲活性成分的組合物
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
IL251456A0 (en) Substances with agonist activity for gpr119, processes for their preparation and preparations containing them
HK1214767A1 (zh) 片劑形式的藥物組合物及其製造方法
EP3323825A4 (en) POLYPEPTIDE COMPOUND, PROCESS FOR PREPARING THE SAME AND USE THEREOF
EP3315508A4 (en) POLYPEPTIDE COMPOUND AND MANUFACTURING METHOD AND USE THEREOF
EP3305283A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING THE SAME
IL262929A (en) Preparations for treatment, methods for their preparation and their uses
SMT202200483T1 (it) Composizione farmaceutica contenente aprepitant e metodo per la sua preparazione
IL258675A (en) Mosquito repellent compounds
IL254597A0 (en) Crystalline form of ahu377, method for its preparation and use
EP3135299A4 (en) Active ingredient (i) containing composition and method for preparing same
HK1213812A1 (zh) 包含 化合物與活性成分的組合物及其製備方法
EP3251672A4 (en) Pharmaceutical composition and preparation method therefor
AP2017009706A0 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
PL3072529T3 (pl) Kompozycja zawierająca wemurafenib i HPMC-AS
SMT202100362T1 (it) Composizione farmaceutica comprendente darunavir e metodo per la preparazione
ZA201404522B (en) Pharmaceutical composition comprising an anticonvulsant active agent and method for the preparation thereof